Related Experiment Video
Updated: Jul 17, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
FGF1 reduces cartilage injury in osteoarthritis via regulating AMPK/Nrf2 pathway
Yun-Xuan Li1, Jun Shu1, Nan-Nan Kou1
1Department of Traumatology, The Second Affiliated Hospital of Kunming Medical University, 374 Dianmian Avenue, Wuhua District, Kunming, 650000, Yunnan, China.
Abstract:
Osteoarthritis (OA) is a systemic joint degenerative disease involving a variety of cytokines and growth factors. In this study, we investigated the protective effect of fibroblast growth factor 1 (FGF1) knockdown on OA and its underlying mechanisms in vitro. In addition, we evaluated the effect of FGF1 knockout on the destabilization of the medial meniscus (DMM) and examined the anterior and posterior cruciate ligament model in vivo. FGF1 affects OA cartilage destruction by increasing the protein expression of Nuclear factor E2-related factor 2 (Nrf2) and heme oxygenase 1 (HO-1), which is associated with the phosphorylation of AMPK and its substrates. Our study showed that FGF1 knockdown could reverse the oxidative damage associated with osteoarthritis. Nrf2 knockdown eliminated the antioxidant effect of FGF1 knockdown on chondrocytes. Furthermore, AMPK knockdown could stop the impact of FGF1 knockdown on osteoarthritis. These findings suggested that FGF1 knockdown could effectively prevent and reverse osteoarthritis by activating AMPK and Nrf2 in articular chondrocytes.
Insights
Fibroblast growth factor 1 (FGF1) knockdown shows protective effects against osteoarthritis (OA) by activating AMPK and Nrf2 pathways. This study reveals FGF1
Area of Science:
- Biochemistry
- Molecular Biology
- Orthopedics
Background:
- Osteoarthritis (OA) is a degenerative joint disease influenced by cytokines and growth factors.
- Fibroblast growth factor 1 (FGF1) role in OA pathogenesis requires further elucidation.
- Oxidative stress and specific molecular pathways are implicated in OA cartilage destruction.
Purpose of the Study:
- To investigate the protective effects of fibroblast growth factor 1 (FGF1) knockdown on osteoarthritis.
- To elucidate the underlying molecular mechanisms of FGF1's involvement in OA.
- To evaluate the in vivo efficacy of FGF1 modulation in OA models.
Main Methods:
- In vitro studies involving FGF1 knockdown in chondrocytes.
- In vivo evaluation using destabilization of the medial meniscus (DMM) and anterior/posterior cruciate ligament transection models.
- Analysis of protein expression (Nrf2, HO-1) and phosphorylation (AMPK).
- Knockdown experiments targeting Nrf2 and AMPK to assess their roles.
Main Results:
- FGF1 knockdown reversed oxidative damage in osteoarthritis models.
- FGF1 knockdown increased protein expression of Nrf2 and HO-1, linked to AMPK phosphorylation.
- Nrf2 knockdown abolished the antioxidant effects of FGF1 knockdown on chondrocytes.
- AMPK knockdown negated the protective impact of FGF1 knockdown in OA.
Conclusions:
- FGF1 knockdown demonstrates a significant protective effect against osteoarthritis.
- The mechanism involves the activation of AMPK and Nrf2 pathways in articular chondrocytes.
- Targeting FGF1 offers a potential therapeutic strategy for preventing and reversing OA.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity

